.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Army
Cipla
Chubb
McKinsey
McKesson
Citi
Express Scripts
Queensland Health
Colorcon

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202330

« Back to Dashboard
NDA 202330 describes BUSPIRONE HYDROCHLORIDE, which is a drug marketed by Oxford Pharms, Mylan, Sandoz, Egis, Apotex, Teva, Amneal Pharms Co, Strides Pharma, Dr Reddys Labs Ltd, Impax Labs Inc, Accord Hlthcare, Nesher Pharms, Heritage Pharma, Ivax Sub Teva Pharms, Orion Corp Orion, and Zydus Pharms Usa Inc, and is included in eighteen NDAs. It is available from forty-nine suppliers. Additional details are available on the BUSPIRONE HYDROCHLORIDE profile page.

The generic ingredient in BUSPIRONE HYDROCHLORIDE is buspirone hydrochloride. There are eighteen drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.

Summary for NDA: 202330

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Anxiolytics
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202330

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUSPIRONE HYDROCHLORIDE
buspirone hydrochloride
TABLET;ORAL 202330 ANDA Strides Shasun Limited 64380-741 64380-741-06 100 TABLET in 1 BOTTLE (64380-741-06)
BUSPIRONE HYDROCHLORIDE
buspirone hydrochloride
TABLET;ORAL 202330 ANDA Strides Shasun Limited 64380-741 64380-741-07 500 TABLET in 1 BOTTLE (64380-741-07)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Aug 25, 2014TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Aug 25, 2014TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Aug 25, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Citi
Farmers Insurance
Harvard Business School
Express Scripts
Johnson and Johnson
Cerilliant
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot